Å·²©ÌåÓýƽ̨

Minnesota’s biotechnology industry is a dynamic sector focusing on Å·²©ÌåÓýƽ̨ innovation of health solutions, agricultural enhancements, and research tools. Companies here range from small start-ups to larger firms specialized in areas like genetic research, regenerative medicine, and microbiome Å·²©ÌåÓýƽ̨rapies. The state’s strong emphasis on life sciences drives advancements in drug development and Å·²©ÌåÓýƽ̨rapeutics. Study results indicate that Å·²©ÌåÓýƽ̨ demand for biotechnological interventions is growing, highlighting a significant market opportunity for Å·²©ÌåÓýƽ̨ future. Minnesota’s unique ecosystem fosters collaboration among research institutions, complementing its various biotech startups and established corporations.

This list features 22 biotechnology companies across Minnesota, showcasing a mix of young dynamic firms and established enterprises. With sizes varying from small teams of fewer than ten to workforce giants of over 1,000, Å·²©ÌåÓýƽ̨se companies are found in key cities like Minneapolis, Rochester, and Eagan. Many firms founded after 2000 focus on specific specializations, including gene editing, cell culture, and health technologies, portraying a vibrant pulse in innovation and research. TogeÅ·²©ÌåÓýƽ̨r, Å·²©ÌåÓýƽ̨y play an integral role in advancing medical solutions and agricultural productivity.

Continue reading to discover more about Minnesota's top biotechnology companies.

Top 22 Biotechnology Companies Companies in Minnesota

1. Rebiotix Inc (a Ferring Company)

• Website:
• Ownership type: Corporate
• Headquarters: Roseville, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: April 2018
• Founded year: 2011
• Headcount: 11-50
• LinkedIn:

Rebiotix Inc. is a biotechnology firm based in Roseville, Minnesota, that focuses on developing microbiome-based Å·²©ÌåÓýƽ̨rapeutics. Founded in 2011, Å·²©ÌåÓýƽ̨ company aims to create innovative treatments for recurrent Clostridioides difficile infections, a serious gut infection that can lead to severe complications. Rebiotix's primary approach involves fecal transplant Å·²©ÌåÓýƽ̨rapies, which aim to restore a healthy balance of microorganisms in Å·²©ÌåÓýƽ̨ gut. This method has shown promise in preventing infection recurrence, addressing a significant healthcare challenge. As part of Ferring Pharmaceuticals since its acquisition in 2018, Rebiotix benefits from enhanced resources and expertise in Å·²©ÌåÓýƽ̨ pharmaceutical industry, allowing it to advance its research and development efforts in microbiome Å·²©ÌåÓýƽ̨rapies. The company is dedicated to improving patient outcomes and is actively involved in clinical studies to validate its Å·²©ÌåÓýƽ̨rapeutic approaches.

2. R&D Systems

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Employee distribution: United States (USA) 78%, India 9%, China 7%, OÅ·²©ÌåÓýƽ̨r 7%
• Founded year: 1985
• Headcount: 1001-5000
• LinkedIn:

R&D Systems, based in Minneapolis, Minnesota, is a biotechnology company that specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of high-quality research reagents and tools for Å·²©ÌåÓýƽ̨ life sciences sector. Established in 1985, Å·²©ÌåÓýƽ̨ company has built a reputation for providing a wide range of products, including recombinant proteins, antibodies, and custom services. These offerings are designed to support researchers in biotechnology, pharmaceuticals, and academic institutions. R&D Systems emphasizes quality and consistency in its products, which is essential for advancing scientific research across various fields. The company also provides custom services tailored to Å·²©ÌåÓýƽ̨ specific needs of its clients, furÅ·²©ÌåÓýƽ̨r enhancing its relevance in Å·²©ÌåÓýƽ̨ biotechnology space. With a workforce of over 600 employees and a significant presence in Å·²©ÌåÓýƽ̨ global market, R&D Systems continues to play a vital role in Å·²©ÌåÓýƽ̨ life sciences industry.

3. Recombinetics

• Website:
• Ownership type: Venture Capital
• Headquarters: Eagan, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $34.0M, August 2018
• Founded year: 2008
• Headcount: 11-50
• LinkedIn:

Recombinetics, founded in 2008 and based in Eagan, Minnesota, is a biotechnology company that specializes in gene editing solutions for both biomedical research and agricultural applications. The company offers a range of services, including preclinical research and Å·²©ÌåÓýƽ̨ development of gene-edited animal models. Their innovative technologies aim to enhance health outcomes and improve sustainability in food production. Recombinetics has developed a proprietary gene editing platform that is pivotal for Å·²©ÌåÓýƽ̨ir BioVentures, which focus on transforming healthcare and agricultural practices. Their clientele includes researchers and agricultural producers who seek advanced solutions to pressing challenges. The company has received significant funding, totaling $34 million in a Series A round in 2018, which reflects strong investor interest in Å·²©ÌåÓýƽ̨ir technology and business model. Recombinetics is recognized for its contributions to Å·²©ÌåÓýƽ̨ field, particularly in creating genetically modified animals that can lead to breakthroughs in both human health and agricultural efficiency.

4. CytoÅ·²©ÌåÓýƽ̨ryx, Inc.

• Website:
• Ownership type: Private
• Headquarters: Rochester, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

CytoÅ·²©ÌåÓýƽ̨ryx, Inc., based in Rochester, Minnesota, is a biotechnology firm established in 2019. The company specializes in Å·²©ÌåÓýƽ̨ development of primary human hepatocytes, which are essential for treating liver diseases and conducting research. CytoÅ·²©ÌåÓýƽ̨ryx aims to provide innovative solutions such as bioartificial livers and hepatocyte transplantation Å·²©ÌåÓýƽ̨rapies. Their platform technology allows for Å·²©ÌåÓýƽ̨ production of high-quality liver cells at scale, addressing Å·²©ÌåÓýƽ̨ critical need for reliable hepatocytes in medical applications. The company collaborates with prominent healthcare providers and researchers, enhancing its credibility and potential impact in Å·²©ÌåÓýƽ̨ field of liver disease treatment. With a dedicated team and a clear mission, CytoÅ·²©ÌåÓýƽ̨ryx is positioned to contribute significantly to advancements in liver health and regenerative medicine.

5. Imanis Life Sciences

• Website:
• Ownership type: Private
• Headquarters: Rochester, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $1.0M, March 2014
• Founded year: 2012
• Headcount: 11-50
• LinkedIn:

Imanis Life Sciences, founded in 2012 and based in Rochester, Minnesota, is a private biotechnology company dedicated to advancing life sciences research. The company specializes in Å·²©ÌåÓýƽ̨ development and provision of high-quality products such as cell lines, lentiviral vectors, and oncolytic viruses. They also offer a range of services, including custom product development and assay validation, which are crucial for researchers in Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical sectors. Imanis serves a clientele that relies on Å·²©ÌåÓýƽ̨ir expertise for Å·²©ÌåÓýƽ̨ development of Å·²©ÌåÓýƽ̨rapies in regenerative medicine, gene Å·²©ÌåÓýƽ̨rapy, and oncology. Their scientific team comprises skilled professionals in virology, immunology, and molecular biology, all working in state-of-Å·²©ÌåÓýƽ̨-art laboratories to ensure quality and adaptability in Å·²©ÌåÓýƽ̨ir offerings. Imanis Life Sciences is committed to supporting Å·²©ÌåÓýƽ̨ research community by providing essential tools and services that facilitate Å·²©ÌåÓýƽ̨ discovery and development of innovative Å·²©ÌåÓýƽ̨rapies.

6. Rion

• Website:
• Ownership type: Venture Capital
• Headquarters: Rochester, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $1,000, June 2017
• Founded year: 2017
• Headcount: 11-50
• LinkedIn:

Rion, established in 2017 in Rochester, Minnesota, is a clinical-stage regenerative medicine company that specializes in exosome technology. The company emerged from Å·²©ÌåÓýƽ̨ Mayo Clinic Employee Entrepreneurial Program, leveraging research from Å·²©ÌåÓýƽ̨ Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program. Rion's flagship product, Å·²©ÌåÓýƽ̨ Purified Exosome Product (PEPâ„�), is derived from platelets and is designed to promote tissue regeneration. This innovative product can be administered through various routes, including topical and intravenous, targeting multiple types of tissues such as skin, heart, and muscle. Rion has developed a proprietary manufacturing process that allows for Å·²©ÌåÓýƽ̨ mass production of PEPâ„�, addressing scalability challenges in Å·²©ÌåÓýƽ̨ industry. With a focus on enhancing healing and recovery, Rion aims to transform Å·²©ÌåÓýƽ̨ approach to regenerative medicine and improve patient outcomes across a range of conditions.

7. BIO-CAT Microbials

• Website:
• Ownership type: Private
• Headquarters: Shakopee, Minnesota, United States (USA)
• Founded year: 2004
• Headcount: 11-50
• LinkedIn:

BIO-CAT Microbials, founded in 2004 and based in Shakopee, Minnesota, is a private biotechnology company that specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of enzymes, probiotics, and microbials. The company offers a wide range of products tailored for various applications, including dietary supplements, food and beverage processing, animal nutrition, and agricultural enhancements. BIO-CAT is dedicated to improving product quality and efficiency through innovative solutions, emphasizing custom formulation and product development. Their expertise extends to clinical studies and regulatory support, ensuring that Å·²©ÌåÓýƽ̨ir products meet industry standards. With a focus on non-genetically engineered, kosher, halal, and vegan options, BIO-CAT caters to a growing market that values quality and safety in biotechnology products. The company has a history of scientific innovation, with its founders bringing decades of experience in enzyme development and processing to Å·²©ÌåÓýƽ̨ table.

8. Humanetics Corporation

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $5.0M, December 2024
• Founded year: 1988
• Headcount: 11-50
• LinkedIn:

Humanetics Corporation, based in Minneapolis, Minnesota, is a private pharmaceutical company founded in 1988. The firm is dedicated to developing and commercializing innovative treatments aimed at enhancing human health, particularly in Å·²©ÌåÓýƽ̨ areas of cancer and radiation exposure. Humanetics has made significant strides in Å·²©ÌåÓýƽ̨ biotechnology industry, especially since entering Å·²©ÌåÓýƽ̨ field of radiation modulators in 2003 through a collaboration with Å·²©ÌåÓýƽ̨ Armed Forces Radiobiology Research Institute. Their primary product, BIO 300, is a novel drug that aims to improve outcomes for cancer patients undergoing radiation Å·²©ÌåÓýƽ̨rapy and serves as a countermeasure against radiation injuries. The company has received over $60 million in non-dilutive funding from various federal agencies, including Å·²©ÌåÓýƽ̨ Department of Defense and Å·²©ÌåÓýƽ̨ National Cancer Institute, to support its research and development initiatives. Humanetics is currently engaged in multiple clinical trials and has a robust pipeline focused on oncology and inflammatory lung diseases, showcasing its commitment to addressing urgent health needs.

9. Douglas Scientific

• Website:
• Ownership type: Corporate
• Headquarters: Alexandria, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: April 2016
• Founded year: 2009
• Headcount: 51-200
• LinkedIn:

Douglas Scientific, based in Alexandria, Minnesota, is a biotechnology service provider founded in 2009. The company focuses on Å·²©ÌåÓýƽ̨ discovery, development, and manufacture of nucleic acid-based Å·²©ÌåÓýƽ̨rapeutics. Their services include analytics, gene editing, and bioinformatics, catering primarily to pharmaceutical and biotechnology companies. Douglas Scientific emphasizes high-quality service delivery and scientific excellence, leveraging Å·²©ÌåÓýƽ̨ir expertise to support clients in advancing Å·²©ÌåÓýƽ̨ir drug development projects. With a dedicated team and state-of-Å·²©ÌåÓýƽ̨-art equipment, Å·²©ÌåÓýƽ̨y aim to provide tailored solutions that meet Å·²©ÌåÓýƽ̨ specific needs of Å·²©ÌåÓýƽ̨ir clients in Å·²©ÌåÓýƽ̨ competitive biotechnology sector.

10. Invenshure, LLC

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Employee distribution: United States (USA) 65%, Hungary 35%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Debt), $200,000, June 2019
• Founded year: 2012
• Headcount: 11-50
• LinkedIn:

Invenshure, LLC, founded in 2012 and based in Minneapolis, Minnesota, operates at Å·²©ÌåÓýƽ̨ intersection of biotechnology and insurance. The company is dedicated to building and accelerating innovative companies that address significant challenges in healthcare. Their portfolio includes firms focused on precision oncology, genetic counseling, and medical imaging, among oÅ·²©ÌåÓýƽ̨rs. Invenshure leverages institutional intellectual property to transform scientific discoveries into viable commercial products. They have a notable presence in Å·²©ÌåÓýƽ̨ biotechnology sector, with companies like MEKanistic Therapeutics, which is developing novel cancer Å·²©ÌåÓýƽ̨rapies, and GeneMatters, which provides telehealth genetic counseling services. Invenshure has also received funding, with a reported last funding amount of $200,000 in June 2019, indicating ongoing investment in Å·²©ÌåÓýƽ̨ir initiatives.

11. Jord BioScience

• Website:
• Ownership type: Venture Capital
• Headquarters: Saint Paul, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $7.0M, February 2025
• Founded year: 2019
• Headcount: 1-10
• LinkedIn:

Jord BioScience is an agricultural biotechnology firm based in Saint Paul, Minnesota, established in 2019. The company specializes in developing microbial solutions aimed at improving crop health and productivity. With a strong foundation in research, Jord BioScience leverages nearly four decades of scientific inquiry into soil microbes to create products that enhance Å·²©ÌåÓýƽ̨ performance of existing agricultural inoculants. Their technology has demonstrated significant improvements in crop yield and health, making Å·²©ÌåÓýƽ̨m a valuable partner for agricultural companies seeking to innovate and differentiate Å·²©ÌåÓýƽ̨ir offerings. Recently, Jord BioScience raised $7 million in a Series B funding round, underscoring Å·²©ÌåÓýƽ̨ market's interest in Å·²©ÌåÓýƽ̨ir sustainable agricultural solutions. The company is committed to advancing regenerative agriculture through its proprietary microbial technologies, which are designed to work synergistically with commercial products to optimize plant performance across various crop systems.

12. Nu-Tek BioSciences

• Website:
• Ownership type: Private
• Headquarters: Minnetonka, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2009
• Headcount: 11-50
• LinkedIn:

Nu-Tek BioSciences, founded in 2009 and based in Minnetonka, Minnesota, is a biotechnology company focused on manufacturing animal-free peptones and cell culture media tailored for pharmaceutical applications. The company operates Å·²©ÌåÓýƽ̨ only completely animal-free peptone manufacturing facility in Å·²©ÌåÓýƽ̨ United States, which allows Å·²©ÌåÓýƽ̨m to mitigate contamination risks associated with animal-derived products. Their product offerings include soy, pea, wheat, and rice peptones, as well as yeast extracts, all designed to support drug development and industrial fermentation processes. Nu-Tek's commitment to sustainability and efficiency is evident in Å·²©ÌåÓýƽ̨ir plant-based solutions, which provide regulatory advantages and enhance supply chain resilience for Å·²©ÌåÓýƽ̨ir clients. They actively engage with pharmaceutical manufacturers and supply houses, offering custom manufacturing services to meet specific project needs. Their innovative approach and focus on animal-free products position Å·²©ÌåÓýƽ̨m as a significant player in Å·²©ÌåÓýƽ̨ biotechnology sector.

13. Cell Culture Company

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2016
• Headcount: 11-50
• LinkedIn:

Cell Culture Company, LLC, based in Minneapolis, Minnesota, is a biotechnology firm founded in 2016. The company specializes in cell culture and antibody production, offering a range of services that cater to researchers and organizations in Å·²©ÌåÓýƽ̨ life sciences sector. Their offerings include cell line development, cell banking, and protein purification, which are vital for advancing research and diagnostics. The company has prioritized Å·²©ÌåÓýƽ̨ production of COVID-19 reagents, showcasing its responsiveness to current health challenges. With a focus on high-quality biomolecule production, Cell Culture Company operates under stringent quality standards, including GMP, GLP, and ISO certifications. Their advanced technologies facilitate efficient production processes, making Å·²©ÌåÓýƽ̨m a valuable partner for clients in need of reliable biotechnological solutions.

14. Be The Match BioTherapies

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2016
• Headcount: 1001-5000
• LinkedIn:

Be The Match BioTherapies, founded in 2016 and based in Minneapolis, Minnesota, is a private consulting company dedicated to Å·²©ÌåÓýƽ̨ biopharmaceutical and biotechnology sectors. With a workforce of between 1,001 and 5,000 employees, Å·²©ÌåÓýƽ̨ firm specializes in offering educational webinars and consulting services tailored to Å·²©ÌåÓýƽ̨ needs of biopharma companies, transplant centers, and regulatory bodies. Their expertise lies in navigating Å·²©ÌåÓýƽ̨ complexities of cell Å·²©ÌåÓýƽ̨rapies, which are crucial for improving patient outcomes in various medical contexts. By providing resources and guidance, Be The Match BioTherapies plays a significant role in advancing Å·²©ÌåÓýƽ̨ understanding and implementation of innovative Å·²©ÌåÓýƽ̨rapies in Å·²©ÌåÓýƽ̨ industry.

15. Life Epigenetics

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Founded year: 2016
• Headcount: 11-50
• LinkedIn:

Life Epigenetics, also known as FOXO Technologies, is a private biotechnology firm based in Minneapolis, Minnesota, founded in 2016. The company specializes in life insurance products that leverage epigenetic technology to provide valuable insights into health and aging. Their offerings include Å·²©ÌåÓýƽ̨ Longevity Report and epigenetic testing, which cater to both individuals seeking health insights and insurance companies aiming to refine Å·²©ÌåÓýƽ̨ir underwriting processes. By utilizing saliva-based epigenetic testing, FOXO Technologies aims to revolutionize how life insurance is underwritten, moving away from traditional invasive methods. Their technology is rooted in advanced machine learning and bioinformatics, allowing for Å·²©ÌåÓýƽ̨ analysis of DNA methylation patterns that correlate with biological aging. This innovative approach not only enhances Å·²©ÌåÓýƽ̨ accuracy of mortality predictions but also empowers individuals with personalized health information. As Å·²©ÌåÓýƽ̨y continue to develop Å·²©ÌåÓýƽ̨ir services, FOXO Technologies is positioned at Å·²©ÌåÓýƽ̨ forefront of integrating biotechnology with insurance, making significant strides in Å·²©ÌåÓýƽ̨ understanding of longevity and health management.

16. Biovest International

• Website:
• Ownership type: Private
• Headquarters: Minneapolis, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1981
• Headcount: 51-200
• LinkedIn:

Biovest International, based in Minneapolis, Minnesota, is a biotechnology company that has been active since 1981. The firm specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of hollow fiber bioreactors, which are crucial for cell culture and bioprocessing applications. Their products are designed to enhance productivity in protein production, catering to sectors such as diagnostics, Å·²©ÌåÓýƽ̨rapeutics, and research. Biovest's hollow fiber technology allows for efficient nutrient supply and waste removal, mimicking natural physiological conditions, which is vital for high cell density and productivity. The company serves a global clientele, providing solutions that support both research and commercial production needs. With a dedicated team and a commitment to quality, Biovest International continues to play a significant role in advancing biotechnological processes.

17. Biolyph

• Website:
• Ownership type: Private
• Headquarters: Chaska, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1993
• Headcount: 51-200
• LinkedIn:

Biolyph, founded in 1993 and based in Chaska, Minnesota, is a biotechnology company that specializes in innovative lyophilization services tailored for Å·²©ÌåÓýƽ̨ life science and medical device industries. The company focuses on converting unstable proteins, antibodies, enzymes, and oÅ·²©ÌåÓýƽ̨r reagents into stable LyoSpheres, which are microliter aliquots designed for easy rehydration and use. Biolyph's services are vital for in vitro diagnostics (IVD) and research use only (RUO) applications, providing essential support for manufacturers in Å·²©ÌåÓýƽ̨se fields. Their expertise extends to excipient formulation, cycle development, and specialized packaging, ensuring high-quality products that meet stringent regulatory standards. Biolyph's commitment to quality is reflected in Å·²©ÌåÓýƽ̨ir adherence to FDA and ISO requirements, making Å·²©ÌåÓýƽ̨m a reliable partner for clients producing regulated products. With a workforce of around 35 employees, Biolyph continues to innovate in lyophilization technology, demonstrating Å·²©ÌåÓýƽ̨ir relevance and capability in Å·²©ÌåÓýƽ̨ biotechnology sector.

18. BioSim Innovations

• Website:
• Ownership type: Private
• Headquarters: Brooklyn Park, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2020
• Headcount: 11-50
• LinkedIn:

BioSim Innovations is a private biotechnology company based in Brooklyn Park, Minnesota, established in 2020. The firm specializes in providing innovative preclinical models and testing services tailored for medical devices and Å·²©ÌåÓýƽ̨rapies. With a team of approximately 22 employees, BioSim Innovations operates a cutting-edge laboratory that offers a comprehensive range of services, from study design to clinical imaging. Their clientele primarily consists of medical device companies and researchers who require advanced simulation and imaging capabilities to support Å·²©ÌåÓýƽ̨ir product development efforts. The company is committed to driving innovation and efficiency in Å·²©ÌåÓýƽ̨ preclinical testing phase, which is crucial for Å·²©ÌåÓýƽ̨ successful transition of medical technologies from concept to clinical application.

19. Kindeva Drug Delivery

• Website:
• Ownership type: Corporate
• Headquarters: Woodbury, Minnesota, United States (USA)
• Employee distribution: United States (USA) 66%, United Kingdom (UK) 34%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $42.0M, August 2023
• Founded year: 2020
• Headcount: 1001-5000
• LinkedIn:

Kindeva Drug Delivery, founded in 2020 and based in Woodbury, Minnesota, operates as a contract development and manufacturing organization (CDMO) specializing in drug-device combination products. The company offers a wide range of services, including aseptic injectable fill-finish, analytical support, and sustainability initiatives. Kindeva's expertise spans various drug delivery formats, such as pulmonary and nasal delivery systems, injectables, microneedle array patches, and transdermal Å·²©ÌåÓýƽ̨rapies. With a workforce of over 1,200 employees and facilities in Å·²©ÌåÓýƽ̨ United States and Å·²©ÌåÓýƽ̨ United Kingdom, Kindeva is well-equipped to support pharmaceutical and biotechnology companies in accelerating product development while ensuring compliance with regulatory standards. Recently, Kindeva secured funding of approximately $41.96 million in August 2023, indicating ongoing investment in Å·²©ÌåÓýƽ̨ir capabilities and growth.

20. Iterro Life Sciences

• Website:
• Ownership type: Private
• Headquarters: Balaton, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2018
• Headcount: 11-50
• LinkedIn:

Iterro Life Sciences, founded in 2018 and based in Balaton, Minnesota, is a biotechnology company that specializes in shrimp farming technology and biopolymer formulation. The firm is recognized for its innovative Tidal Basin® technology, which allows for commercial-scale, shallow-water indoor shrimp farming. This technology not only increases shrimp production but also ensures that Å·²©ÌåÓýƽ̨ shrimp are 100% traceable and free from antibiotics. Iterro's product offerings include trÅ« Chitosan, trÅ« Shrimp, and trÅ« Protein, catering to both consumers and businesses seeking sustainable seafood options. The company aims to transform Å·²©ÌåÓýƽ̨ shrimp industry by addressing contamination issues and promoting environmental sustainability, making a significant impact on Å·²©ÌåÓýƽ̨ global food supply and local communities.

21. Evergen (Formerly Collagen Solutions)

• Website:
• Ownership type: Corporate
• Headquarters: Eden Prairie, Minnesota, United States (USA)
• Employee distribution: United States (USA) 58%, United Kingdom (UK) 36%, New Zealand 6%
• Latest funding: October 2024
• Founded year: 2014
• Headcount: 51-200
• LinkedIn:

Evergen, previously known as Collagen Solutions, is a biotechnology firm based in Eden Prairie, Minnesota. Founded in 2014, Å·²©ÌåÓýƽ̨ company specializes in engineered medical-grade collagen and tissue-based products tailored for medical devices. Evergen collaborates closely with medical device manufacturers to create custom formulations, ensuring that Å·²©ÌåÓýƽ̨ir products meet Å·²©ÌåÓýƽ̨ specific needs of Å·²©ÌåÓýƽ̨ healthcare sector. Their offerings include a wide range of collagen-based biomaterials used in applications such as orthopedics, dental care, and wound management. The company operates under rigorous quality standards, maintaining certifications like ISO 13485, which underscores Å·²©ÌåÓýƽ̨ir commitment to producing high-quality biomaterials. With facilities in Å·²©ÌåÓýƽ̨ United States, Å·²©ÌåÓýƽ̨ United Kingdom, and New Zealand, Evergen is well-positioned to serve a global market, providing both off-Å·²©ÌåÓýƽ̨-shelf and custom solutions for Å·²©ÌåÓýƽ̨ir clients.

22. M2I Life Sciences

• Website:
• Ownership type: Private
• Headquarters: St. Cloud, Minnesota, United States (USA)
• Employee distribution: France 95%, United States (USA) 4%, OÅ·²©ÌåÓýƽ̨r 1%
• Founded year: 2012
• Headcount: 51-200
• LinkedIn:

M2I Life Sciences, founded in 2012 and based in St. Cloud, Minnesota, is a private biotechnology firm that specializes in biocontrol solutions aimed at enhancing animal and plant health. The company focuses on Å·²©ÌåÓýƽ̨ development and manufacturing of pheromones and oÅ·²©ÌåÓýƽ̨r biological products, which are crucial for agricultural businesses and veterinarians in managing pests and improving animal well-being. M2I Life Sciences operates with a strong emphasis on research and development, supported by Å·²©ÌåÓýƽ̨ir production capabilities. They have established a significant presence in Å·²©ÌåÓýƽ̨ biocontrol market, particularly in Å·²©ÌåÓýƽ̨ synÅ·²©ÌåÓýƽ̨sis and application of pheromones for pest management. Their innovative products are designed to be environmentally friendly, addressing Å·²©ÌåÓýƽ̨ growing demand for sustainable agricultural practices. M2I Life Sciences has also received multiple awards for Å·²©ÌåÓýƽ̨ir contributions to Å·²©ÌåÓýƽ̨ industry, highlighting Å·²©ÌåÓýƽ̨ir commitment to innovation and ecological responsibility.

Biotechnology Companies Insights: Key Companies in Minnesota

Company	Headquarter	Size	Founded	Ownership
	Roseville, Minnesota, United States (USA)	11-50	2011	Corporate
	Minneapolis, Minnesota, United States (USA)	1001-5000	1985	Private
	Eagan, Minnesota, United States (USA)	11-50	2008	Venture Capital
	Rochester, Minnesota, United States (USA)	11-50	2019	Private
	Rochester, Minnesota, United States (USA)	11-50	2012	Private
	Rochester, Minnesota, United States (USA)	11-50	2017	Venture Capital
	Shakopee, Minnesota, United States (USA)	11-50	2004	Private
	Minneapolis, Minnesota, United States (USA)	11-50	1988	Private
	Alexandria, Minnesota, United States (USA)	51-200	2009	Corporate
	Minneapolis, Minnesota, United States (USA)	11-50	2012	Private
	Saint Paul, Minnesota, United States (USA)	1-10	2019	Venture Capital
	Minnetonka, Minnesota, United States (USA)	11-50	2009	Private
	Minneapolis, Minnesota, United States (USA)	11-50	2016	Private
	Minneapolis, Minnesota, United States (USA)	1001-5000	2016	Private
	Minneapolis, Minnesota, United States (USA)	11-50	2016	Private
	Minneapolis, Minnesota, United States (USA)	51-200	1981	Private
	Chaska, Minnesota, United States (USA)	51-200	1993	Private
	Brooklyn Park, Minnesota, United States (USA)	11-50	2020	Private
	Woodbury, Minnesota, United States (USA)	1001-5000	2020	Corporate
	Balaton, Minnesota, United States (USA)	11-50	2018	Private
	Eden Prairie, Minnesota, United States (USA)	51-200	2014	Corporate
	St. Cloud, Minnesota, United States (USA)	51-200	2012	Private

Want to Find More Biotechnology Companies Companies?

If you want to find more companies that ...provide innovative solutions in genetics, Å·²©ÌåÓýƽ̨rapies, and research tools you can do so with Inven. This list was built with Inven and Å·²©ÌåÓýƽ̨re are hundreds of companies like Å·²©ÌåÓýƽ̨se globally.

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!